3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
fludarabine phosphate
2
Psychiatric Rehabilitation
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Mycophenolic Acid
2
Methylprednisolone
2
Lenalidomide
2
Cyclosporine
2
Antilymphocyte Serum
2
tazarotenic acid
1
tazarotene
1
sintilimab
1
romidepsin
1
motesanib diphosphate
1
mogamulizumab
1
carbendazim
1
Valproic Acid
1
VAP-cyclo protocol
1
Ultraviolet Therapy
1
Therapeutics
1
Ritonavir
1
Radiotherapy
1
Polymerase Chain Reaction
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Methoxsalen
1
Methotrexate
1
Melphalan
1
Levofloxacin
1
Leucovorin
1
Ketamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, T-Cell, Cutaneous
×
Blood Specimen Collection
×
Clear all
NCT02539472
2016-04-18
DIAPREMYF
Assistance Publique - Hôpitaux de Paris
Phase NA
Unknown
620 enrolled